The incidence of vasculitides in Israel from 2007 to 2021 and during the COVID-19 pandemic

The incidence of various types of vasculitis conditions over time, specifically during coronavirus disease 2019 (COVID-19), is unknown. We aimed to assess recent trends in vasculitides and the effect of the COVID-19 pandemic on these trends. We conducted a retrospective analysis of Israel's lar...

Full description

Saved in:
Bibliographic Details
Published inTherapeutic advances in musculoskeletal disease Vol. 16; p. 1759720X241274032
Main Authors Zeller, Lior, Ben David, Ran, Novack, Lena, Abuhasira, Ran, Abu-Shakra, Mahmoud, Miskin, Yuval, Sagy, Iftach
Format Journal Article
LanguageEnglish
Published England SAGE Publications 01.01.2024
SAGE Publishing
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The incidence of various types of vasculitis conditions over time, specifically during coronavirus disease 2019 (COVID-19), is unknown. We aimed to assess recent trends in vasculitides and the effect of the COVID-19 pandemic on these trends. We conducted a retrospective analysis of Israel's largest Health Maintenance Organization, which covers over 4.7 million patients and represents 55% of the country. We calculated the age- and sex-adjusted incidence of giant cell arteritis (GCA), Takayasu, ANCA-associated vasculitis (AAV), IgA vasculitis, cryoglobulinemia, and Behcet's disease (BD) during 2007-2021. We analyzed associations of COVID-19 with the incidence of each of the examined conditions. During 2007-2021, the adjusted annual incidence decreased from 7.9 (95% confidence interval (CI) 3.5-17.9) to 1.5 (95% CI 0.7-3.6) per 100,000 for GCA, from 5.2 (95% CI 2.7-11.1) to 1.5 (95% CI 0.7-3.3) per million for IgA vasculitis, and from 6.3 (95% CI 3.0-13.5) to 1.0 (0.5-2.5) per 100,000 for BD. The relative risks for these conditions decreased: 0.92 (95% CI 0.91-0.93), 0.93 (95% CI 0.89-0.98), and 0.90 (95% CI 0.85-0.94), respectively. The incidences of Takayasu, AAV, and cryoglobulinemia remained unchanged. The COVID-19 pandemic was not associated with changes in the incidence of any examined vasculitides. The incidences of GCA, IgA vasculitis, and BD decreased substantially in Israel during 15 years and were unaffected by the COVID-19 pandemic. Future studies should focus on possible environmental contributions to these findings.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally
ISSN:1759-720X
1759-7218
DOI:10.1177/1759720X241274032